Abstract |
Inhibition of the growth of the human ovarian cancer cell line A2780 by organometallic ruthenium(II) complexes of the type [(eta(6)-arene)Ru(X)(Y)(Z)], where arene is benzene or substituted benzene, X, Y, and Z are halide, acetonitrile, or isonicotinamide, or X,Y is ethylenediamine (en) or N-ethylethylenediamine, has been investigated. The X-ray crystal structures of the complexes [(eta(6)- p-cymene)Ru(en)Cl]PF(6) (5), [(eta(6)- p-cymene)RuCl(2)( isonicotinamide)] (7), and [(eta(6)- biphenyl)Ru(en)Cl]PF(6) (9) are reported. They have "piano stool" geometries with eta(6) coordination of the arene ligand. Complexes with X,Y as a chelated en ligand and Z as a monofunctional leaving group had the highest activity. Complexes 5, 6 (the iodo analogue of 5), 9, and 10 (ethylethylenediamine analogue of 9) were as active as carboplatin. Hydrolysis of the reactive Ru-Cl bond in complex 5 was detected by HPLC but was suppressed by the addition of chloride ions. Complex 5 binds strongly and selectively to G bases on DNA oligonucleotides to form monofunctional adducts. No inhibition of topoisomerase I or II by complexes 5, 6, or 9 was detected. These chelated Ru(II) arene complexes have potential as novel metal-based anticancer agents with a mechanism of action different from that of the Ru(III) complex currently on clinical trial.
|
Authors | R E Morris, R E Aird, P del S Murdoch, H Chen, J Cummings, N D Hughes, S Parsons, A Parkin, G Boyd, D I Jodrell, P J Sadler |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 44
Issue 22
Pg. 3616-21
(Oct 25 2001)
ISSN: 0022-2623 [Print] United States |
PMID | 11606126
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- DNA Adducts
- Enzyme Inhibitors
- Oligonucleotides
- Organometallic Compounds
- Topoisomerase I Inhibitors
- Topoisomerase II Inhibitors
- Ruthenium
|
Topics |
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Crystallography, X-Ray
- DNA Adducts
(chemistry)
- Drug Screening Assays, Antitumor
- Enzyme Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Humans
- Molecular Structure
- Oligonucleotides
(chemistry)
- Organometallic Compounds
(chemical synthesis, chemistry, pharmacology)
- Ruthenium
- Structure-Activity Relationship
- Topoisomerase I Inhibitors
- Topoisomerase II Inhibitors
- Tumor Cells, Cultured
|